AmerisourceBergen Pays $625M To Resolve Drug Repackaging False Claims Allegations
(October 2, 2018, 2:10 PM EDT) -- BROOKLYN, N.Y. — Drug wholesaler AmerisourceBergen Corp. and four subsidiaries have agreed to pay $625 million to resolve civil allegations that they improperly repackaged cancer drugs into prefilled syringes, resulting in...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login